Uttar Pradesh government planned to open Six Pharma Parks

Six Pharma Parks has been planned to set-up in the Uttar Pradesh state as the state has been received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma companies.

Sidharth Nath Singh, Uttar Pradesh health minister said that the conversation is going with several big multinational companies like Mylan, GE, Pfizer and Sanofi with our domestic companies for setting up pharma units in the state. He also added that state already contributing 30% in the pharma manufacturing and exports of medicinal goods. New pharma policy had announced around three months back and have already received an investment commitment of about Rs 5,000-6,000 crore, of which we can hope that several will materialize soon.

Sidharth Nath Singh also said during his speech at the annual celebration event, the sidelines of the Organisation of Pharmaceutical Producers of India (OPPI), the parks have been planned to set up in Noida, Bundelkhand, Ghaziabad, Gorakhpur, Lucknow, and Allahabad, which will help in achieving faster growth.

He also announced that the state government will allot 100 to 250 acres of land and offer incentives like free electricity, zero stamp duty, an interest-free loan up to Rs 10 crore for the infrastructure development.

He also added that government also reimbursing for five to seven years the state GST component. The government planned to give capital intensive subsidy in the form of reimbursement to 60 percent (up to Rs 50 lakh for the maximum unit) for the R&D support. The state also offers a single window system and follow ethical practices.

Singh also highlighted that Centre’s Ayushman Bharat is a big initiative and programme and our initiative will be the backbone of implementing this. He also added the achievements of the state like state government has already reached out to 1,000 private and public hospitals and is reaching out to 1,000 more.

Singh also said that the government already running a huge training programme for the ASHA, ANMs and Anganwadi workers in the state to speed up the training process.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices